-
1
-
-
0033545541
-
Rising incidence of hepatocellular carcinoma in the United States
-
El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750.
-
(1999)
N Engl J Med
, vol.340
, pp. 745-750
-
-
El-Serag, H.B.1
Mason, A.C.2
-
2
-
-
3242760687
-
Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence
-
Moore SW, Millar AJ, Hadley GP, et al. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence. Cancer. 2004;101:642-649.
-
(2004)
Cancer
, vol.101
, pp. 642-649
-
-
Moore, S.W.1
Millar, A.J.2
Hadley, G.P.3
-
3
-
-
42949174616
-
Diagnosis and treatment of hepatocellular carcinoma
-
El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752-1763.
-
(2008)
Gastroenterology
, vol.134
, pp. 1752-1763
-
-
El-Serag, H.B.1
Marrero, J.A.2
Rudolph, L.3
-
5
-
-
0037129704
-
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
-
Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734-1739.
-
(2002)
Lancet
, vol.359
, pp. 1734-1739
-
-
Llovet, J.M.1
Real, M.I.2
Montana, X.3
-
6
-
-
0037308133
-
Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival
-
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429-442.
-
(2003)
Hepatology
, vol.37
, pp. 429-442
-
-
Llovet, J.M.1
Bruix, J.2
-
7
-
-
0037421597
-
Nephrotoxic effects in high-risk patients undergoing angiography
-
Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-499.
-
(2003)
N Engl J Med
, vol.348
, pp. 491-499
-
-
Aspelin, P.1
Aubry, P.2
Fransson, S.G.3
-
8
-
-
0024552764
-
Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study
-
Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med. 1989;320:143-149.
-
(1989)
N Engl J Med
, vol.320
, pp. 143-149
-
-
Parfrey, P.S.1
Griffiths, S.M.2
Barrett, B.J.3
-
9
-
-
35848968871
-
Prevalence of chronic kidney disease in the United States
-
Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047.
-
(2007)
JAMA
, vol.298
, pp. 2038-2047
-
-
Coresh, J.1
Selvin, E.2
Stevens, L.A.3
-
10
-
-
0034816961
-
Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis
-
Cardenas A, Gines P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001;34:671-676.
-
(2001)
Hepatology
, vol.34
, pp. 671-676
-
-
Cardenas, A.1
Gines, P.2
Uriz, J.3
-
11
-
-
2442665085
-
Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome
-
Huo TI, Wu JC, Huang YH, et al. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome. Aliment Pharmacol Ther. 2004;19:999-1007.
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 999-1007
-
-
Huo, T.I.1
Wu, J.C.2
Huang, Y.H.3
-
12
-
-
28844480321
-
Management of hepatocellular carcinoma
-
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
14
-
-
33645976468
-
Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score
-
Huo TI, Lin HC, Lee FY, et al. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Liver Int. 2006;26:55-61.
-
(2006)
Liver Int
, vol.26
, pp. 55-61
-
-
Huo, T.I.1
Lin, H.C.2
Lee, F.Y.3
-
15
-
-
0036191173
-
Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998
-
Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716-721.
-
(2002)
Hepatology
, vol.35
, pp. 716-721
-
-
Ferenci, P.1
Lockwood, A.2
Mullen, K.3
-
16
-
-
85046525006
-
Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma
-
The CLIP Investigators. Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology. 2000;32:679-680.
-
(2000)
Hepatology
, vol.32
, pp. 679-680
-
-
-
17
-
-
0036176161
-
DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
-
(2002)
Am J Kidney Dis
, vol.39
-
-
-
18
-
-
1242329504
-
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations
-
Gonwa TA, Jennings L, Mai ML, et al. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl. 2004;10:301-309.
-
(2004)
Liver Transpl
, vol.10
, pp. 301-309
-
-
Gonwa, T.A.1
Jennings, L.2
Mai, M.L.3
-
20
-
-
22844436304
-
Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients
-
Poggio ED, Nef PC, Wang X, et al. Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis. 2005;46:242-252.
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 242-252
-
-
Poggio, E.D.1
Nef, P.C.2
Wang, X.3
-
21
-
-
33745283670
-
Prophylaxis strategies for contrast-induced nephropathy
-
Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006;295:2765-2779.
-
(2006)
JAMA
, vol.295
, pp. 2765-2779
-
-
Pannu, N.1
Wiebe, N.2
Tonelli, M.3
-
22
-
-
10244236377
-
Acute renal failure- definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
-
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure- definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204-R212.
-
(2004)
Crit Care
, vol.8
-
-
Bellomo, R.1
Ronco, C.2
Kellum, J.A.3
-
23
-
-
0023634583
-
Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study
-
Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med. 1987;82:945-952.
-
(1987)
Am J Med
, vol.82
, pp. 945-952
-
-
Papadakis, M.A.1
Arieff, A.I.2
-
25
-
-
0036245381
-
Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test
-
Huang YS, Chiang JH, Wu JC, et al. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol. 2002;97:1223-1227.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 1223-1227
-
-
Huang, Y.S.1
Chiang, J.H.2
Wu, J.C.3
-
26
-
-
31344440606
-
Clinical practice. Preventing nephropathy induced by contrast medium
-
Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354:379-386.
-
(2006)
N Engl J Med
, vol.354
, pp. 379-386
-
-
Barrett, B.J.1
Parfrey, P.S.2
-
27
-
-
38049086969
-
Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
-
Cho YK, Chung JW, Kim JK, et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112:352-361.
-
(2008)
Cancer
, vol.112
, pp. 352-361
-
-
Cho, Y.K.1
Chung, J.W.2
Kim, J.K.3
-
28
-
-
0034942301
-
Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis
-
Hampel H, Bynum GD, Zamora E, et al. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol. 2001;96:2206-2210.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2206-2210
-
-
Hampel, H.1
Bynum, G.D.2
Zamora, E.3
-
29
-
-
0035146422
-
A model to predict survival in patients with end-stage liver disease
-
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-470.
-
(2001)
Hepatology
, vol.33
, pp. 464-470
-
-
Kamath, P.S.1
Wiesner, R.H.2
Malinchoc, M.3
-
30
-
-
3142669115
-
Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study
-
Huo TI, Wu JC, Lee PC, et al. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int. 2004;24:210-215.
-
(2004)
Liver Int
, vol.24
, pp. 210-215
-
-
Huo, T.I.1
Wu, J.C.2
Lee, P.C.3
-
31
-
-
33646683337
-
Contrast-induced nephropathy: a clinical and evidence-based approach
-
Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113:1799-1806.
-
(2006)
Circulation
, vol.113
, pp. 1799-1806
-
-
Tepel, M.1
Aspelin, P.2
Lameire, N.3
-
32
-
-
51849099423
-
Contrast medium-induced nephropathy: strategies for prevention
-
Massicotte A. Contrast medium-induced nephropathy: strategies for prevention. Pharmacotherapy. 2008;28:1140-1150.
-
(2008)
Pharmacotherapy
, vol.28
, pp. 1140-1150
-
-
Massicotte, A.1
-
33
-
-
33845402644
-
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies
-
Marelli L, Stigliano R, Triantos C, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007;30:6-25.
-
(2007)
Cardiovasc Intervent Radiol
, vol.30
, pp. 6-25
-
-
Marelli, L.1
Stigliano, R.2
Triantos, C.3
-
34
-
-
0028936849
-
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study
-
Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995;47:254-261.
-
(1995)
Kidney Int
, vol.47
, pp. 254-261
-
-
Rudnick, M.R.1
Goldfarb, S.2
Wexler, L.3
-
35
-
-
33746926391
-
Contrast-induced nephropathy: definition, epidemiology, and patients at risk
-
Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int. 2006;100:S11-S15.
-
(2006)
Kidney Int
, vol.100
-
-
Mehran, R.1
Nikolsky, E.2
-
37
-
-
34548139321
-
The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey
-
Huo TI, Lin HC, Hsia CY, et al. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey. Am J Gastroenterol. 2007;102:1920-1930.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 1920-1930
-
-
Huo, T.I.1
Lin, H.C.2
Hsia, C.Y.3
-
38
-
-
33748271906
-
The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy
-
Huo TI, Lee PC, Huang YH, et al. The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy. J Clin Gastroenterol. 2006;40:543-550.
-
(2006)
J Clin Gastroenterol
, vol.40
, pp. 543-550
-
-
Huo, T.I.1
Lee, P.C.2
Huang, Y.H.3
-
39
-
-
33745320148
-
The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy
-
Huo TI, Lin HC, Huang YH, et al. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer. 2006;107:141-148.
-
(2006)
Cancer
, vol.107
, pp. 141-148
-
-
Huo, T.I.1
Lin, H.C.2
Huang, Y.H.3
-
40
-
-
34848854859
-
Causes of death in patients with unresectable hepatocellular carcinoma
-
Couto OF, Dvorchik I, Carr BI. Causes of death in patients with unresectable hepatocellular carcinoma. Dig Dis Sci. 2007;52:3285-3289.
-
(2007)
Dig Dis Sci
, vol.52
, pp. 3285-3289
-
-
Couto, O.F.1
Dvorchik, I.2
Carr, B.I.3
-
41
-
-
0031837430
-
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
-
Huo TI, Wu JC, Lee PC, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology. 1998;28:231-236.
-
(1998)
Hepatology
, vol.28
, pp. 231-236
-
-
Huo, T.I.1
Wu, J.C.2
Lee, P.C.3
-
42
-
-
0017237541
-
Low serum bilirubin in chronic renal failure. Relation to haem metabolism
-
Pasternack A, Tenhunen R. Low serum bilirubin in chronic renal failure. Relation to haem metabolism. Clin Chim Acta. 1976;67:85-92.
-
(1976)
Clin Chim Acta
, vol.67
, pp. 85-92
-
-
Pasternack, A.1
Tenhunen, R.2
|